Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: David Y. Thomas |
| Publication date | March 3, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |